62053-06-9 Usage
General Description
6-(2-Hydroxyethyl)-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7(4H)-one is a chemical compound belonging to the category of triazolopyrimidines. Its molecular formula is C9H10N4O2 and the molecular weight is 206.204 g/mol. This chemical is not naturally occurring and must be synthesized in the laboratory using specific reactions. As its name suggests, it features a pyrimidine ring fused with a triazole ring, substituted with prominent functional groups such as methyl and hydroxyethyl groups. Currently, there isn't much information available about the specific properties, use or the potential hazard of this chemical. Every person who handles this chemical or any other synthetic compounds should always follow the standard lab safety protocols to prevent potential risks.
Check Digit Verification of cas no
The CAS Registry Mumber 62053-06-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,2,0,5 and 3 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 62053-06:
(7*6)+(6*2)+(5*0)+(4*5)+(3*3)+(2*0)+(1*6)=89
89 % 10 = 9
So 62053-06-9 is a valid CAS Registry Number.
InChI:InChI=1/C8H10N4O2/c1-5-6(2-3-13)7(14)12-8(11-5)9-4-10-12/h4,13H,2-3H2,1H3,(H,9,10,11)
62053-06-9Relevant articles and documents
PYRROLO [3, 2 -E] [1,2,4] TRIAZOLO [1,5 -A] PYRIMIDINES DERIVATIVES AS INHIBITORS OF MICROGLIA ACTIVATION
-
Page/Page column 7-8, (2011/04/26)
The invention relates to novel compounds useful in the treatment and prophylaxis of disease. Compounds of the formula (I) wherein X is halogen, independently selected form chlorine and fluorine and n is 0, 1 or 2. and their pharmaceutically acceptable salts are useful in the treatment and prophylaxis of diseases caused by activation of microglia, particularly Alzheimer's disease.
Studies on Cardiovascular Agents. 6. Synthesis and Coronary Vasodilating and Antihypertensive Activities of 1,2,4-Triazolopyrimidines Fused to Heterocyclic Systems
Sato, Yasunobu,Shimoji, Yasuo,Fujita, Hiroshi,Nishino, Hiroshi,Mizuno, Hiroshi,et al.
, p. 927 - 937 (2007/10/02)
The synthesis and coronary vasodilating and antihypertensive activities of 1,2,4-triazolopyrimidines fused to pyrrole, thiophene, pyran, pyridine, and pyridazine are described.Among these compounds, 8-tert-butyl-7,8-dihydro-5-methyl-6H-pyrrolo3,2-
